Buy 25C-NBOH for sale online from USA vendor
Table of Contents
-
Introduction
- Overview of 25C-NBOH
- History and Synthesis
-
Chemistry
- Chemical Structure
- Pharmacology
- Receptor Affinity
-
Subjective Effects
- Physical Effects
- Visual Effects
- Cognitive Effects
- Auditory Effects
- Multi-sensory Effects
- Transpersonal Effects
-
Toxicity and Harm Potential
- Risks and Concerns
- Tolerance and Addiction Potential
- Dangerous Interactions
-
Legal Status
-
FAQ (Frequently Asked Questions)
Understanding 25C-NBOH: A Novel Synthetic Psychedelic
Introduction to 25C-NBOH
25C-NBOH, also referred to as 2C-C-NBOH and NBOH-2C-C, is an emerging synthetic psychedelic compound belonging to the phenethylamine chemical class. This substance induces a range of visually dominant and stimulating psychedelic effects upon administration. Similar to its counterpart, 25B-NBOMe, it shares most properties, albeit with a slightly reduced potency and shorter duration.
Origins and Synthesis
The nomenclature 25C-NBOH stems from its association with 2C-C, a well-known phenethylamine psychedelic. Martin Hansen, based at the University of Copenhagen, first synthesized and documented this compound in 2011, marking its initial introduction into scientific discourse.
Administration and Consumption
It's essential to note that members of the NBOH family, including 25C-NBOH, are not orally active. The recommended method of consumption involves sublingual administration. Users are advised to place the substance under the tongue and hold it there for 15-25 minutes, allowing for absorption.
Pharmacological Properties and Safety Concerns
Despite its growing popularity, there remains a dearth of knowledge regarding the pharmacological properties, metabolism, and toxicity of 25C-NBOH in humans. Prior to its emergence as a designer drug in 2011, it lacked any documented history of human use. This lack of data is concerning, especially given its close relation to the 25x-NBOMe series, which has been linked to numerous hospitalizations and fatalities.
Anecdotal reports hint at the challenges associated with safely using 25C-NBOH. Its highly sensitive dose-response curve and unpredictable effects underscore the importance of cautious and informed consumption practices.
Understanding Dosage of 25C-NBOH
Threshold Dosage
The threshold dosage for 25C-NBOH, the minimum amount required to elicit any noticeable effects, is reported to be 100 µg.
Light Dosage
At light doses, users typically experience subtle effects. The range for light dosage falls between 250 to 500 µg.
Common Dosage
A common dosage of 25C-NBOH typically induces moderate psychedelic effects. This range extends from 500 to 750 µg.
Strong Dosage
At strong doses, the psychedelic effects of 25C-NBOH become pronounced. This range varies between 750 to 1000 µg.
Heavy Dosage
Heavy doses of 25C-NBOH can be exceptionally dangerous, potentially leading to fatal consequences. It is advised to avoid doses exceeding 1000 µg due to the heightened risk of severe adverse reactions and even death.
Unveiling the Chemistry of 25C-NBOH
Chemical Structure
25C-NBOH, also known as 2C-C-NBOH, belongs to the serotonergic N-benzyl derivatives of the substituted phenethylamine psychedelic 2C-C. Structurally, it is a substituted phenethylamine featuring methoxy groups (CH3O-) attached to carbons R2 and R5, as well as a bromine atom attached to carbon R4. The distinctive modification distinguishing it from 2C-C is the substitution on the amine (NH2) with a 2-hydroxybenzyl (BOH) group. This shared 2-hydroxybenzyl substitution characterizes other members of the NBOH family, consisting of a hydroxy ether (OH-) bound to a benzene ring at R2.
Unraveling the Pharmacology of 25C-NBOH
Receptor Affinity
25C-NBOH primarily targets the 5-HT2A receptor, where it acts as a potent agonist. Its pharmacological uniqueness lies in its exceptionally high selectivity for various serotonin receptors. Notably, it ranks among the most selective agonist ligands for the 5-HT2A receptor, boasting a pEC50 value of 9.43. Additionally, it acts as a potent serotonin receptor agonist, exhibiting similar affinity to the well-known compound 25C-NBOMe at 5-HT2A and 5-HT2C receptors, with pKis values of 9.4 and 7.8, respectively. However, the precise mechanisms through which these interactions translate into the psychedelic experience remain largely elusive.
Subjective Effects
Physical Effects
- Stimulation: Users commonly experience a high level of physical energy, described as extremely energetic yet not necessarily inducing involuntary movement.
- Perception of Bodily Lightness: Users often report feeling unusually light, sometimes to the point of total weightlessness.
- Spontaneous Physical Sensations: A mild, euphoric tingling sensation accompanied by rushes of euphoria is frequently reported.
- Mouth Numbing: Sublingual administration is marked by a strong metallic taste and numbness in the tongue and mouth.
- Nausea: Initial nausea may occur during the onset but typically diminishes as the trip progresses.
- Temperature Regulation Suppression
- Increased Bodily Temperature
- Abnormal Heartbeat
- Increased Heart Rate
- Increased Blood Pressure
- Muscle Contractions
- Muscle Cramps
- Muscle Tension
- Gustatory Hallucination
- Vasoconstriction
- Appetite Suppression
- Stomach Cramps
- Dehydration
- Dry Mouth
- Difficulty Urinating or Frequent Urination
- Restless Legs
- Pupil Dilation
- Headaches
- Seizures
Visual Effects
- Enhancements: Visual acuity, color, and pattern recognition.
- Distortions: Drifting, color shifting, depth perception distortions, etc.
- Geometry: Intricate, algorithmic patterns, similar to LSD.
- Hallucinatory States: Transformations, machinescapes, internal hallucinations, etc.
Cognitive Effects
- Analysis Enhancement
- Thought Acceleration
- Conceptual Thinking
- Anxiety & Paranoia
- Feelings of Impending Doom
- Empathy, Affection, and Sociability Enhancement
- Memory Suppression
- Ego Death
- Amnesia
- Novelty Enhancement
- Immersion Enhancement
- Emotion Enhancement
- Increased Sense of Humor
- Laughter Fits
- Increased Music Appreciation
- Personal Bias Suppression
- Increased Libido
- Time Distortion
- Wakefulness
Auditory Effects
- Auditory Enhancement
- Auditory Distortion
- Auditory Hallucination
Multi-sensory Effects
- Dosage Independent Intensity
- Synaesthesia
Transpersonal Effects
- Existential Self-Realization
- Unity and Interconnectedness
Toxicity and Harm Potential
25C-NBOH's toxicity and potential for harm are areas of concern due to its novelty and limited research. Similar to other substances in the 25x-NBOMe series, it is presumed to pose acute health risks, potentially leading to fatalities at heavy doses. Insufflation (snorting) is particularly dangerous, associated with numerous deaths and hospitalizations. However, further research is required to determine its exact LD50 and long-term effects.
Tolerance and Addiction Potential
While 25C-NBOH is not considered habit-forming, tolerance to its effects develops rapidly after ingestion. Cross-tolerance with other psychedelics is observed, necessitating caution with subsequent use to avoid diminished effects.
Dangerous Interactions
Combining 25C-NBOH with certain substances can pose significant risks, including psychosis, seizures, anxiety, and paranoia. Caution is advised, particularly when using it in conjunction with lithium, cannabis, stimulants, tramadol, or other psychoactive compounds.
Legal Status
The legal status of 25C-NBOH varies by country. For example, it is classified as a controlled substance in countries like Brazil, Germany, Sweden, and Switzerland. In the United Kingdom, it is designated as a Class A drug.
FAQ (Frequently Asked Questions)
Q: What is 25C-NBOH?
A: 25C-NBOH, also known as 2C-C-NBOH, is a synthetic psychedelic compound belonging to the phenethylamine chemical class. It induces a range of visually dominant and stimulating psychedelic effects upon administration.
Q: How is 25C-NBOH synthesized?
A: 25C-NBOH is synthesized from 2C-C through a series of chemical reactions, typically involving substitutions and modifications on the phenethylamine structure.
Q: What are the common dosage ranges for 25C-NBOH?
A: The common dosage ranges for 25C-NBOH are as follows:
- Threshold: 100 µg
- Light: 250 - 500 µg
- Common: 500 - 750 µg
- Strong: 750 - 1000 µg
- Heavy: >1000 µg (potentially fatal)
Q: What are the subjective effects of 25C-NBOH?
A: The subjective effects include a wide range of physical, visual, cognitive, and auditory alterations. These effects can vary in intensity and duration depending on the dosage and individual response.
Q: Is 25C-NBOH safe to use?
A: There are significant safety concerns associated with 25C-NBOH, including its potential for toxicity, dangerous interactions with other substances, and the risk of adverse reactions at high doses. Caution and informed decision-making are essential when considering its use.
Q: What is the legal status of 25C-NBOH?
A: The legal status of 25C-NBOH varies by country. It is classified as a controlled substance in several countries, while in others, it may be subject to specific regulations governing its production, distribution, and use.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics